TAVT-18 (sirolimus) ( DrugBank: Sirolimus )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
158結節性硬化症1

158. 結節性硬化症


臨床試験数 : 112 薬物数 : 71 - (DrugBank : 19) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 118
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04595513
(ClinicalTrials.gov)
September 8, 20206/10/2020Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC InfantsStopping TSC Onset and Progression 2: Epilepsy Prevention in TSC InfantsTuberous Sclerosis Complex;EpilepsyDrug: TAVT-18 (sirolimus)Children's Hospital Medical Center, CincinnatiNULLActive, not recruitingN/A6 MonthsAll5Phase 1/Phase 2United States